Total Payments
$66,629
2024 Payments
$551.36
Companies
17
Transactions
75
Medicare Patients
20,498
Medicare Billing
$20.5M
Payment Breakdown by Category
Other$62,234 (93.4%)
Food & Beverage$4,395 (6.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $33,259 | 1 | 49.9% |
| Current or prospective ownership or investment interest | $28,975 | 6 | 43.5% |
| Food and Beverage | $4,395 | 62 | 6.6% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$66,629
69 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US Retina LLC | $62,234 | 13 | $0 (2022) |
| Dutch Ophthalmic, USA | $916.29 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $776.25 | 21 | $0 (2024) |
| Allergan, Inc. | $645.09 | 6 | $0 (2021) |
| Alimera Sciences, Inc. | $545.49 | 6 | $0 (2023) |
| Genentech USA, Inc. | $393.74 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $211.40 | 4 | $0 (2024) |
| Alcon Vision LLC | $151.86 | 2 | $0 (2023) |
| Coherus Biosciences Inc. | $135.00 | 1 | $0 (2023) |
| NotalVision | $114.59 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $551.36 | 8 | Genentech USA, Inc. ($185.55) |
| 2023 | $1,017 | 15 | Regeneron Healthcare Solutions, Inc. ($369.08) |
| 2022 | $42,937 | 14 | US Retina LLC ($42,512) |
| 2021 | $13,533 | 14 | US Retina LLC ($13,043) |
| 2020 | $3,402 | 6 | US Retina LLC ($2,890) |
| 2019 | $4,042 | 4 | US Retina LLC ($3,790) |
| 2018 | $210.90 | 4 | Allergan Inc. ($158.36) |
| 2017 | $935.34 | 10 | Dutch Ophthalmic, USA ($283.72) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $143.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $77.28 | General |
| Category: Ophthalmology | ||||||
| 05/16/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $93.24 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $42.07 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/06/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $132.87 | General |
| Category: Ophthalmology | ||||||
| 02/06/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: EYE CARE | ||||||
| 01/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Ophthalmology | ||||||
| 01/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $138.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/29/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: EYE CARE | ||||||
| 10/26/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Ophthalmology | ||||||
| 10/18/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $134.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $57.85 | General |
| 09/12/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Ophthalmology | ||||||
| 08/29/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: EYE CARE | ||||||
| 07/13/2023 | Alimera Sciences, Inc. | YUTIQ (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/10/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/16/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $119.60 | General |
| Category: Ophthalmology | ||||||
| 02/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $166.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Ophthalmology | ||||||
| 12/19/2022 | US Retina LLC | — | Acquisitions | Cash or cash equivalent | $33,258.50 | General |
| 08/26/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $14.81 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 5,228 | 39,861 | $15.7M | $6.0M |
| 2022 | 22 | 5,088 | 24,140 | $14.0M | $5.2M |
| 2021 | 21 | 5,040 | 17,993 | $12.7M | $4.9M |
| 2020 | 21 | 5,142 | 17,697 | $11.6M | $4.5M |
Total Patients
20,498
Total Services
99,691
Medicare Billing
$20.5M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 380 | 5,086 | $9.2M | $3.5M | 38.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 48 | 19,140 | $1.5M | $558,018 | 38.4% |
| J3490 | Unclassified drugs | Office | 2023 | 86 | 311 | $1.5M | $549,992 | 37.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 87 | 3,240 | $997,920 | $389,968 | 39.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 540 | 3,070 | $842,483 | $280,484 | 33.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 39 | 980 | $470,730 | $182,817 | 38.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 491 | 1,559 | $268,148 | $95,478 | 35.6% |
| 92134 | Imaging of retina | Office | 2023 | 961 | 3,210 | $250,884 | $89,572 | 35.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 819 | 922 | $223,138 | $74,726 | 33.5% |
| J3590 | Unclassified biologics | Office | 2023 | 49 | 160 | $198,450 | $50,289 | 25.3% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 24 | 230 | $64,630 | $49,471 | 76.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 231 | 297 | $73,762 | $25,968 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $47,640 | $15,856 | 33.3% |
| 92250 | Photography of the retina | Office | 2023 | 538 | 599 | $43,888 | $15,037 | 34.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 14 | 15 | $32,760 | $12,831 | 39.2% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 15 | 15 | $34,080 | $12,747 | 37.4% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 11 | 11 | $18,788 | $7,362 | 39.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 68 | 69 | $17,836 | $6,477 | 36.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 498 | 599 | $19,156 | $6,401 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 42 | $14,622 | $5,268 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $9,844 | $3,800 | 38.6% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 100 | 116 | $5,572 | $2,069 | 37.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 20 | 20 | $5,724 | $1,907 | 33.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 369 | 5,068 | $9.6M | $3.6M | 37.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 51 | 1,930 | $1.2M | $427,296 | 34.3% |
About Dr. Scott Pendergast, M.D
Dr. Scott Pendergast, M.D is a Ophthalmology healthcare provider based in Beachwood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386638682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Pendergast, M.D has received a total of $66,629 in payments from pharmaceutical and medical device companies, with $551.36 received in 2024. These payments were reported across 75 transactions from 17 companies. The most common payment nature is "Acquisitions" ($33,259).
As a Medicare-enrolled provider, Pendergast has provided services to 20,498 Medicare beneficiaries, totaling 99,691 services with total Medicare billing of $20.5M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Beachwood, OH
- Active Since 09/01/2005
- Last Updated 06/28/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1386638682
Products in Payments
- EVA Ophthalmic Surgical System (Device) $663.82
- EYLEA (Biological) $585.04
- OZURDEX (Drug) $450.58
- Iluvien (Drug) $252.89
- EVA, combined machine (Device) $252.47
- EYLEA HD (Biological) $191.21
- ILUVIEN (Drug) $167.60
- Susvimo (Drug) $143.48
- NGENUITY (Device) $137.22
- Vabysmo (Drug) $135.31
- Cimerli (Biological) $135.00
- Lucentis (Biological) $125.00
- YUTIQ (Drug) $125.00
- Syfovre (Drug) $116.15
- ForeseeHome (Device) $114.59
- ACTHAR (Biological) $100.00
- XIPERE (Drug) $100.00
- VABYSMO (Drug) $83.19
- PICO (Device) $52.54
- FLEXITOUCH (Device) $37.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Beachwood
Joseph Coney, M.d, M.D
Ophthalmology — Payments: $917,427
Ophthalmology $917,427
Dr. Lawrence Singerman, M.d, M.D
Ophthalmology — Payments: $645,745
Ophthalmology $645,745
Michael Novak, Md, MD
Ophthalmology — Payments: $71,246
Ophthalmology $71,246
Dr. Llewelyn Rao, Md, MD
Ophthalmology — Payments: $67,486
Ophthalmology $67,486
Dr. Jerome Schartman, M.d, M.D
Ophthalmology — Payments: $30,841
Ophthalmology $30,841
Lediana Goduni, Md, MD
Ophthalmology — Payments: $13,399
Ophthalmology $13,399